Botulinum toxin therapy in the ovalbumin-sensitized rat

NeuroImmunoModulation

Volumn 14, Issue 2, 2007, Pages 78-83

  Wen, Wei Dong ^a,b   Yuan, Fang ^a   Wang, Jian Lin ^a   Hou, Yi Ping ^a  

^a LANZHOU UNIVERSITY   (China)

^b NORTH MINZU UNIVERSITY   (China)

Author keywords

Allergic rhinitis; Botulinum toxin type A; Ovalbumin; Substance P; Vasoactive intestinal peptide

Indexed keywords

BOTULINUM TOXIN A; NEUROPEPTIDE; OVALBUMIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; BLOOD VESSEL; CONTROLLED STUDY; DRUG EFFICACY; EPITHELIUM; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; NASAL PRURITUS; NONHUMAN; NOSE MUCOSA; NOSE SECRETION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RHINORRHEA; SENSITIZATION; SNEEZING;

ADMINISTRATION, INTRANASAL; ALLERGENS; ANIMALS; BOTULINUM TOXIN TYPE A; FEMALE; IMMUNOHISTOCHEMISTRY; NASAL MUCOSA; OVALBUMIN; RATS; RATS, WISTAR; RHINITIS, ALLERGIC, SEASONAL; SUBSTANCE P; VASOACTIVE INTESTINAL PEPTIDE;

EID: 34548819329     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107422     Document Type: Article

References (28)

1. 2-Macroglobulin and eosinophil cationic protein in the allergic airway mucosa in seasonal allergic rhinitis. Eur Respir J 1999;13:633-637.
2. Erjefält JS, Greiff L, Andersson M, Mattsson E, Peterson H, Linden M, Ansari T, Jeffery PK, Persson CGA: Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways. Am J Respir Crit Care Med 1999;160:304-312.
3. Baraniuk JN: Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa. J Allergy Clin Immunol 1992;90:1045-1050.
4. White MV, Kaliner MA: Mediators of allergic rhinitis. J Allergy Clin Immunol 1992;90:699-704.
5. Fajac I, Braunstein G, Lckovic MR, Lacronique J, Frossard N: Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis. Allergy 1995;50:970-975.
6. Barnes PJ: Neurogenic inflammation in the airway. Respir Physiol 2001;125:145-154.
7. Korsgren M, Erjefält JS, Hinterhölzl J, Fischer-Colbrie R, Emanuelsson CA, Andersson M, Persson CGA, Mackay-Sim A, Sundler F, Geiff L: Neural expression and increased lavage fluid levels of secretoneurin in seasonal allergic rhinitis. Am J Respir Crit Care Med 2003;167:1504-1508.
8. Naclerio RM: Allergic rhinitis. N Eng J Med 1991;325:860-869.
9. Oosten VMCM, Pelikan HMP, Ossekoppele R, Pelikan Z: Pharmacologic modulation of the cytologic changes in the nasal secretions (NS) accompanying the immediate nasal response to allergen challenge [INR]. J Allergy Clin Immunol 1997;99:S445.
10. Fouke JM, Jackson AC: Acoustic rhinometry: effects of decongestants and posture on nasal patency. J Lab Clin Med 1992;19:371-376.
11. Malm L, Wihl JA: Intranasal beclomethasone dipropionate in vasomotor rhinitis. Acta Allergol 1976;31:227-238.
12. Unal M, Sevim S, Dogu O, Vayisoglu Y, Kanik: Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: double-blind, placebo-controlled clinical trial. Act Otolaryngol 2003;123:1060-1063.
13. Jankovic J, Brin MF: Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-1194.
14. Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, de Camilli P, Sudhof TC, Niemann H, Jahn R: Botulinum toxin A selectively cleaves the synaptic protein SNAP-25. Nature 1993;365:160-163.
15. Saito H, Matsumoto K, Denburg AE, Crawford L, Ellis R, Inman MD, Sehmi R, Takatsu K, Matthaei KI, Denburg JA: Pathogenesis of murine experimental allergic rhinitis: a study of local and systemic consequences of IL-5 deficiency. J Immunol 2002;168:3017-3023.
16. Melgert BN, Postma DS, Kuipers I, Geerlings M, Luinger MA, van de Strate BWA, Kerstjens HAM, Timens W, Hylkema MN: Female mice are more susceptible to the development of allergic airway inflammation than male mice. Clin Exp Allergy 2005;35:1496-1503.
17. Assanasen P, Baroody FM, Rouadi P, Naureckas E, Solway J, Naclerio RM: Ipratropium bromide increases the ability of the nose to warm and humidify air. Am J Respir Crit Care Med 2000;162:1031-1037.
18. Brozmanova M, Calkovsky V, Plevkova J, Bartos V, Tatar M, Plank L: Early and late allergic phase related cough response in sensitized guinea pigs with experimental allergic rhinitis. Physiol Res 2006;55:577-584.
19. 2 adrenergic receptors suggests different sleep-wake state activities and roles. Neuroscience 2002;114:517-521.
20. Hou YP, Song YF: The distribution of type B monoamine oxidase immunoreactivity inhibited by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the cat. Chin J Neurosci 1999;15:279-284.
21. Bellamy JL, Cady RK, Durham PL: Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients. Headache 2006;46:24-33.
22. Ficher A, Wussow A, Cryer A, Schmeck B, Noga O, Zweng M, Peiser C, Dinh QT, Heppt W, Groneberg DA: Neuronal plasticity in persistent perennial allergic rhinitis. J Occup Environ Med 2005;47:20-25.
23. Heppt W, Peiser C, Cryer A, Dinh QT, Zweng M, Witt C, Ficher A, Groneberg DA: Innervation of human nasal mucosa in environmentally triggered hyperreflectoric rhinitis. J Occup Environ Med 2003;44:924-929.
24. De Camilli P: Exocytosis goes with a SNAP. Nature 1993;364:387-388.
25. Hoogerwerf WA, Pasricha PJ: Pharmacologic therapy in treating achalasia. Gastrointest Endosc Clin N Am 2001;11:311-322.
26. Lacy BE, Zayat EN, Crowell MD, Schuster MM: Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol 2002;97:1548-1552.
27. Ishikawa H, Mitsui Y, Yoshitomi T, Mashimo K, Aoki S, Mukuno K, Shimizu K: Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles. Jpn J Ophthalmol 2000;44:106-109.
28. Morris JL, Jobling P, Gibbins IL: Differential inhibition by botulinum neurotoxin A of co-transmitters released from autonomic vasodilator neurons. Am J Physiol Heart Circ Physiol 2001;281:H2124-H2132.